Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

September 30, 2001

Study Completion Date

March 31, 2003

Conditions
Vitreous HemorrhageDiabetic Retinopathy
Interventions
DRUG

Vitrase

7.5 IU of Vitrase

DRUG

Vitrase

55 IU of Vitrase

DRUG

Vitrase

75 IU of Vitrase

Trial Locations (73)

10021

Ronni M. Lieberman, MD, New York

11021

Long Island Vitreo Retinal Consultants, Great Neck

13224

Retina Vitreous Surgeons of Central NY, Syracuse

19104

Scheie Eye Institute, Philadelphia

19107

Retina Research of Wills Eye Hospital, Philadelphia

19606

Carim Eye & Retina Center, Wyomissing

20817

Retina Consultants, PC, Bethesda

21204

Retina Specialists, Baltimore

21287

Wilmer Eye Institute/Johns Hopkins University School of Medicine, Baltimore

24016

Vista Retinal Consultants, Roanoke

27612

Carolina Eye Associates, PA, Raleigh

28210

Charlotte Eye, Ear, Nose & Throat Association, Charlotte

32701

Florida Eye Clinic, Altamonte Springs

33614

Scott E. Pautler, MD, Tampa

33901

Eye Centers of Florida, Fort Myers

34239

Sarasota Retina Institute, Sarasota

37203

Retina-Vitreous Associates, Nashville

37920

Southeastern Retina Associates, PC, Knoxville

43210

Retina Consultants, Ohio State University, Columbus

44195

Cleveland Clinic Foundation, Cleveland

Retina Associates of Cleveland, Cleveland

47150

American Eye Institute, New Albany

49525

VitreoRetinal Associates, Grand Rapids

53226

Medical College of Wisconsin, Milwaukee

55404

Retina Center PA, Minneapolis

60612

Illinois Retina Associates SC, Chicago

60637

University of Chicago, Chicago

63110

The Center for Advanced Medicine/Barnes Retina Institute, St Louis

64111

Hunkeler Eye Centers, Kansas City

64151

Retina Associates of Kansas City, Kansas City

66202

King Y. Lee, MD, Shawnee Mission

66208

Felix N. Sabates Eye Associates, Prairie Village

70115

Kurt A. Gitter, MD, New Orleans

73104

Dean A. McGee Eye Institute, Oklahoma City

77002

Retinal Vascular Center, Houston

77030

Cullen Eye Institute/Baylor College of Medicine, Houston

78503

Valley Retina Institute, PA, McAllen

80262

University of Colorado Health Sciences Center, Denver

80909

Retina Consultants of Southern Colorado, Colorado Springs

84132

John Moran Eye Center, Salt Lake City

85704

Retina Centers, PC, Tucson

90211

Retina Vitreous Associates Medical Group, Beverly Hills

91342

Olive View/UCLA Medical Center, Sylmar

91910

Maria E. Castillejos, MD, Chula Vista

92262

Southern California Desert Retina Consultants, Palm Springs

92647

Jerry Sebag, MD, Huntington Beach

92697

University of California, Irvine, Irvine

93103

Robert L. Avery, MD, Santa Barbara

93710

Natural Vision, Fresno

93721

Eye Medical Center of Fresno, Fresno

94025

California VitreRetinal Center, Menlo Park

94109

H. Richard McDonald, MD, San Francisco

95128

Santa Clara Valley Medical Centre, San Jose

95819

Retinal Consultants, Sacramento

96701

Retina Center at Pali Momi, ‘Aiea

98101

Virginia Mason Medical Center, Seattle

06810

Danbury Eye Physicians & Surgeons, Danbury

06518

New England Retina Associates, Hamden

02215

Schepens Retina Associates, Boston

08701

Robert Wood Johnson Medical School/Retina Vitreous Center, New Brunswick

07666

Retina Associates of New Jersey, Teaneck

V5Z 3N9

Vancouver Eye Care Center/University of British Columbia, Vancouver

B3H 2Y9

Dalhousie University, Halifax

N6A 4G5

Ivey Institute of Ophthalmology, London

K1H 8L6

University of Ottawa Eye Institute, Ottawa

M2P 1E3

Toronto Western Hospital, Toronto

H3A 1A1

Royal Victoria Hospital, Montreal

G1V 4G2

Centre Hospitalier de l'Universite Laval (CHUL), Sainte-Foy

S4T 1A5

The Medical Centre Pasqua Hospital, Regina

S7K 0M7

Saskatoon City Hospital, Saskatoon

06080

Instituto de Oftalmologia, Fundacion Conde de Valenciana, Col. Obrera

04030

Association Para Evitar la Ceguera en Mexico, Coyacan

06030

Fundacion Hospital, Nuestra Senora de la Luz IAP, Cuahtemoc

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00198510 - Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage | Biotech Hunter | Biotech Hunter